One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
Antisense oligonucleotide-directed liver therapy: a new tool in the MASH armamentarium?
Excess weight loss and safety outcomes from the randomised SADISLEEVE trial
Global cost of silencing science: editors and publishers have a duty to resist
Plastics in health care: rethinking medical device innovation, use, and disposal for sustainability
Clarity in gender-inclusive language in reproductive health care
INTERLACE: not a new standard for cervical cancer chemoradiation
INTERLACE: not a new standard for cervical cancer chemoradiation – Authors' reply
Progress towards global nutrition targets and future directions – Authors' reply
Safety and efficacy of steroidal mineralocorticoid receptor antagonists in patients with kidney failure requiring dialysis: a systematic review and meta-analysis of randomised controlled trials
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Building community capacity in mental health care with the Strong Minds–Strong Communities programme: a randomised controlled trial in the USA
Efficacy and safety of single-anastomosis duodeno-ileal bypass with sleeve gastrectomy versus Roux-en-Y gastric bypass in France (SADISLEEVE): results of a randomised, open-label, superiority trial at 2 years of follow-up
Surgical health policy 2025–35: strengthening essential services for tomorrow's needs
